Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?
Alongi F, Arcangeli S, Ramella S, Giaj-Levra N, Borghetti P, D'angelillo R, Ricchetti F, Maddalo M, Mazzola R, Trovò M, Russi E, Magrini SM; on the behalf of Associazione Italiana Radioterapia Oncologica (AIRO). Alongi F, et al. Among authors: russi e. Expert Rev Anticancer Ther. 2017 Feb;17(2):157-165. doi: 10.1080/14737140.2017.1273111. Epub 2017 Jan 5. Expert Rev Anticancer Ther. 2017. PMID: 27984919 Review.
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer.
Vigna-Taglianti R, Russi EG, Boriano A, Gianello L, Denaro N, Lucio F, Arena G, Buglione M, Pergolizzi S, Ricardi U, Magrini S. Vigna-Taglianti R, et al. Urol Oncol. 2014 Jan;32(1):30.e1-7. doi: 10.1016/j.urolonc.2012.10.011. Epub 2013 Feb 12. Urol Oncol. 2014. PMID: 23410946
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Paganelli C, Majorana A, Gastaldi G, Bossi P, Berruti A, Pavanato G, Nicolai P, Maroldi R, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Among authors: russi eg. Crit Rev Oncol Hematol. 2016 Jan;97:131-42. doi: 10.1016/j.critrevonc.2015.08.010. Epub 2015 Aug 12. Crit Rev Oncol Hematol. 2016. PMID: 26318095 Review.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Bossi P, Majorana A, Gastaldi G, Berruti A, Trippa F, Nicolai P, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Among authors: russi eg. Crit Rev Oncol Hematol. 2016 Jun;102:47-54. doi: 10.1016/j.critrevonc.2016.03.012. Epub 2016 Mar 11. Crit Rev Oncol Hematol. 2016. PMID: 27061883 Review.
Extreme hypofractionation for early prostate cancer: Biology meets technology.
De Bari B, Arcangeli S, Ciardo D, Mazzola R, Alongi F, Russi EG, Santoni R, Magrini SM, Jereczek-Fossa BA; on the behalf of the Italian Association of Radiation Oncology (AIRO). De Bari B, et al. Cancer Treat Rev. 2016 Nov;50:48-60. doi: 10.1016/j.ctrv.2016.08.005. Epub 2016 Aug 29. Cancer Treat Rev. 2016. PMID: 27631875 Review.
466 results